As for their regional specificity for TD, the expression of CX3CR1 was found to be upregulated in the (postmortem) striatum of TD patients (FC = 1.78) [64] and increased CX3CL1 blood expression is correlated with increased TD symptom severity [67]. Here, CX3CL1 is linked to thanatophoric dysplasia.